Elanco Animal Health Incorporated
ELAN
$21.43
-$0.29-1.34%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -164.88% | -168.64% | -82.44% | 134.58% | 128.65% |
| Total Depreciation and Amortization | 7.28% | 4.34% | 8.55% | 4.85% | -0.80% |
| Total Amortization of Deferred Charges | -28.21% | -22.50% | -58.33% | -50.00% | -39.06% |
| Total Other Non-Cash Items | 109.42% | 102.14% | 98.82% | -157.49% | -154.53% |
| Change in Net Operating Assets | -17.98% | -33.56% | -129.29% | 561.11% | 334.21% |
| Cash from Operations | 7.85% | 3.51% | 20.73% | 2.69% | 27.99% |
| Capital Expenditure | -39.36% | -87.76% | -85.11% | -59.85% | -34.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -1,266.67% | -1,266.67% |
| Divestitures | -100.00% | -99.34% | -99.34% | 1,874.24% | 1,874.24% |
| Other Investing Activities | -72.73% | 14.29% | -100.00% | -650.00% | -- |
| Cash from Investing | -126.43% | -124.09% | -125.14% | 1,652.24% | 1,480.52% |
| Total Debt Issued | 232.78% | 364.21% | -5.26% | 5.26% | 44.00% |
| Total Debt Repaid | -30.66% | -42.74% | 60.39% | -141.65% | -173.67% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -161.54% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 130.00% | 164.71% | 247.83% | 1,856.25% | 23.08% |
| Cash from Financing | 72.26% | 81.57% | 81.93% | -254.81% | -397.54% |
| Foreign Exchange rate Adjustments | 186.05% | 178.02% | -42.86% | 48.00% | -43.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -141.55% | -33.62% | -87.60% | 151.02% | 425.93% |